These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
507 related items for PubMed ID: 16215309
1. Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range. Kefi A, Irer B, Ozdemir I, Tuna B, Goktay Y, Yorukoğlu K, Esen A. Urol Int; 2005; 75(3):222-6. PubMed ID: 16215309 [Abstract] [Full Text] [Related]
3. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection. Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981 [Abstract] [Full Text] [Related]
4. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy]. Cao XL, Gao JP, Han G, Tang J, Hong BF. Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):372-5. PubMed ID: 16638344 [Abstract] [Full Text] [Related]
5. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels. Dinçel C, Caşkurlu T, Taşçi AI, Cek M, Sevin G, Fazlioğlu A. Int Urol Nephrol; 1999 Mar 15; 31(4):497-509. PubMed ID: 10668945 [Abstract] [Full Text] [Related]
6. Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy? Oh JJ, Jeong SJ, Jeong CW, Byun SS, Hong SK, Choe G, Lee SE. Prostate; 2013 Jan 15; 73(1):42-7. PubMed ID: 22585359 [Abstract] [Full Text] [Related]
8. [Comparison of prostate volume measured by transrectal and abdominal echography and its implication for the measurement of the PSA density for the diagnosis of prostate cancer]. Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, Lennie Zucharino A, González Galán A. Arch Esp Urol; 2002 Sep 15; 55(7):797-806. PubMed ID: 12380308 [Abstract] [Full Text] [Related]
10. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Porter CR, Kim J. Urology; 2004 Jan 15; 63(1):90-4. PubMed ID: 14751356 [Abstract] [Full Text] [Related]
12. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? Ohori M, Dunn JK, Scardino PT. Urology; 1995 Nov 15; 46(5):666-71. PubMed ID: 7495118 [Abstract] [Full Text] [Related]
15. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases. Kang SH, Bae JH, Park HS, Yoon DK, Moon DG, Kim JJ, Cheon J. Int J Urol; 2006 Jul 15; 13(7):910-4. PubMed ID: 16882054 [Abstract] [Full Text] [Related]
16. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations. Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A. Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025 [Abstract] [Full Text] [Related]